Literature DB >> 10323208

Selective accumulation of CCR5+ T lymphocytes into inflamed joints of rheumatoid arthritis.

N Suzuki1, A Nakajima, S Yoshino, K Matsushima, H Yagita, K Okumura.   

Abstract

Chemokines and their receptors play critical roles in the selective recruitment of various subsets of leukocytes. Recent studies have indicated that some chemokine receptors are differentially expressed on Th1 and Th2 cells. However, available data concerning the presence of T cells with a Th1 or a Th2 character and the expression of chemokine receptors on infiltrating T cells in the rheumatic joint are still limited. In this study, we investigated the expression of CC chemokine receptor 4 (CCR4) and CCR5, which have been shown to be preferentially expressed on Th2 and Th1 respectively on T cells from rheumatoid arthritis (RA) patients. Although both CCR5+ and CCR4+ CD4+ T cell populations were observed in peripheral blood mononuclear cells from healthy controls and osteoarthritis patients, these cell populations were decreased in patients with active RA. In contrast, the vast majority of synovial fluid (SF) T cells from active RA patients expressed CCR5 but not CCR4. CCR5 ligands, MIP-1alpha and RANTES, were found in RA SF at high levels. CCR5+ CD4+ T cells from SF mononuclear cells of RA patients produced IFN-gamma but not IL-4 in response to anti-CD3 stimulation in vitro. These results indicated that differential expression of chemokine receptors plays a critical role for selective recruitment of pro-inflammatory T cells into the joints of RA.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10323208     DOI: 10.1093/intimm/11.4.553

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  34 in total

Review 1.  Immune chemokines and their receptors: the key elements in the genesis, homeostasis and function of the immune system.

Authors:  O Yoshie
Journal:  Springer Semin Immunopathol       Date:  2000

Review 2.  Regulation of Th1 and Th2 immune responses by chemokines.

Authors:  H Yoneyama; S Kawasaki; K Matsushima
Journal:  Springer Semin Immunopathol       Date:  2000

3.  Expression of the chemokine receptors CCR4, CCR5, and CXCR3 by human tissue-infiltrating lymphocytes.

Authors:  Eric J Kunkel; Judie Boisvert; Kristine Murphy; Mark A Vierra; Mark C Genovese; Andrew J Wardlaw; Harry B Greenberg; Martin R Hodge; Lijun Wu; Eugene C Butcher; James J Campbell
Journal:  Am J Pathol       Date:  2002-01       Impact factor: 4.307

4.  Surface expression of CC- and CXC-chemokine receptors on leucocyte subsets in inflammatory joint diseases.

Authors:  H Brühl; K Wagner; H Kellner; M Schattenkirchner; D Schlöndorff; M Mack
Journal:  Clin Exp Immunol       Date:  2001-12       Impact factor: 4.330

5.  The strength of the chemotactic response to a CCR5 binding chemokine is determined by the level of cell surface CCR5 density.

Authors:  Caroline Desmetz; Yea-Lih Lin; Clément Mettling; Pierre Portalès; Herisoa Rabesandratana; Jacques Clot; Pierre Corbeau
Journal:  Immunology       Date:  2006-12       Impact factor: 7.397

6.  Peripheral blood T4 cell surface CCR5 density as a marker of activity in rheumatoid arthritis treated with anti-CD20 monoclonal antibody.

Authors:  Pierre Portalès; Sylvie Fabre; Thierry Vincent; Caroline Desmetz; Brigitte Réant; Danièle Noël; Jacques Clot; Christian Jorgensen; Pierre Corbeau
Journal:  Immunology       Date:  2009-03-26       Impact factor: 7.397

Review 7.  The roles of catabolic factors in the development of osteoarthritis.

Authors:  Dominick J Blasioli; David L Kaplan
Journal:  Tissue Eng Part B Rev       Date:  2013-12-11       Impact factor: 6.389

8.  The chemokine receptor CCR5 plays a role in post-traumatic cartilage loss in mice, but does not affect synovium and bone.

Authors:  K Takebe; M F Rai; E J Schmidt; L J Sandell
Journal:  Osteoarthritis Cartilage       Date:  2014-12-09       Impact factor: 6.576

9.  Excitatory amino acids, TNF-alpha, and chemokine levels in synovial fluids of patients with active arthropathies.

Authors:  T McNearney; B A Baethge; S Cao; R Alam; J R Lisse; K N Westlund
Journal:  Clin Exp Immunol       Date:  2004-09       Impact factor: 4.330

Review 10.  Application of cellular gene therapy for rheumatoid arthritis.

Authors:  Atsuo Nakajima
Journal:  Mod Rheumatol       Date:  2006       Impact factor: 3.023

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.